Tiopronin Tablet, Delayed Release
Product Images NDC 44523-055

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tiopronin (NDC 44523-055). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Biocomp Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ade Tiopronin Ag Table 1)

This text shows a breakdown of adverse reactions reported among patients in two different groups, one previously treated with d-penicillamine and the other group being naive to the treatment. Adverse reactions such as anemia, nausea, emesis, abdominal pain, oral ulcers, fatigue, chest pain, arthralgia, proteinuria, impotence, cough, rash, ecchymosis, pruritus, urticaria, and skin wrinkling are listed along with their respective occurrence rates within the two groups. These statistics provide valuable information on the potential side effects associated with d-penicillamine treatment.*

FDA Label Image

Image (Ade Tiopronin Ag Table 2)

This table lists adverse reactions reported for Tiopronin tablets by System Organ Class and Preferred Term. Adverse reactions include congestive heart failure under Cardiac Disorders, vertigo under Ear and Labyrinth Disorder, and a variety of symptoms under Gastrointestinal Disorders, General Disorders, Investigations, Metabolism and Nutrition Disorders, Musculoskeletal and Connective Tissue Disorders, Nervous System Disorders, Renal and Urinary Disorders, and Skin and Subcutaneous Tissue Disorders. Symptoms such as abdominal pain, diarrhea, dry mouth, jaundice, fatigue, chest pain, weight increase, joint swelling, and headache are described.*

FDA Label Image

Image (Tinidazole Biocomp Logo)

This is a label from a pharmaceutical product manufactured by BioComp Pharma, Inc. based in San Antonio, Texas. The product code is BCP013R0423.*

FDA Label Image

Label (Tiopronin 100mg Label)

FDA Label Image

Label (Tiopronin 300mg Label)

FDA Label Image

Image (Tiopronin Structure)

Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.